Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis

Retrovirology

Volumn 9, Issue , 2012, Pages

  Zheng, Qi ^a   Ruone, Susan ^a   Switzer, William M ^a   Heneine, Walid ^a   García Lerma, J G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Emtricitabine; Pre exposure prophylaxis; Single genome amplification; Truvada

Indexed keywords

EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;

ACUTE DISEASE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG TREATMENT FAILURE; ENVELOPE GENE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; INFECTION PREVENTION; MALE; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; RHESUS MONKEY; SEQUENCE ANALYSIS; TREATMENT DURATION; VIREMIA; VIRUS IMMUNITY; VIRUS MUTANT; VIRUS TRANSMISSION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-HIV AGENTS; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; EVOLUTION, MOLECULAR; GENE PRODUCTS, ENV; GENETIC VARIATION; GENOME, VIRAL; MACACA MULATTA; MALE; ORGANOPHOSPHORUS COMPOUNDS; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA;

ANIMALIA; MACACA; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84860868080     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-40     Document Type: Article

References (28)

1. García-Lerma JG, Paxton L, Kilmarx P, Heneine W. Oral pre-exposure prophylaxis for HIV prevention. Trends Pharmacol Sci 2010, 31:74-81. 10.1016/j.tips.2009.10.009, 19963288.
2. Thigpen MC, Kebaabetswe PM, Smith DK, Segolodi TM, Soud FA, Chillag K, Chirwa LI, Kasonde M, Mutanhaurwa R, Henderson FL, Pathak S, Gvetadze R, Rose CE, Paxton LA. Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study 2011, International AIDS Society meeting, Rome.
3. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV, . iPrEx Study Team Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010, 363:2587-2599. 10.1056/NEJMoa1011205, 3079639, 21091279, iPrEx Study Team.
4. Baeten J. Antiretroviral Pre-Exposure Prophylaxis for HIV-1 prevention among heterosexual African men and women: the Partners PrEP Study 2011, International AIDS Society meeting, Rome.
5. Varela M, Landskron L, Lai RP, McKinley TJ, Bogers WM, Verschoor EJ, Dubbes R, Barnett SW, Frost SD, Heeney JL. Molecular evolution analysis of the human immunodeficiency virus type 1 envelope in simian/human immunodeficiency virus-infected macaques: implications for challenge dose selection. J Virol 2011, 85:10332-10345. 10.1128/JVI.05290-11, 3196462, 21795341.
6. García-Lerma JG, Aung W, Cong ME, Zheng Q, Youngpairoj AS, Mitchell J, Holder A, Martin A, Kuklenyik S, Luo W, Lin CY, Hanson DL, Kersh E, Pau CP, Ray AS, Rooney JF, Lee WA, Heneine W. Natural substrate concentrations can modulate the prophylactic erfficacy of nucleotide HIV reverse transcriptase inhibitors. J Virol 2011, 85:6610-6617. 10.1128/JVI.00311-11, 3126530, 21525346.
7. García-Lerma JG, Cong M, Mitchell J, Youngpairoj AS, Zheng Q, Masciotra S, Martin A, Kuklenyik Z, Holder A, Lipscomnb J, et al. Intermittent prophylaxis with oral truvada protects macques form rectal SHIV infection. Sci Transl Med 2010, 2:14ra14.
8. García-Lerma JG, Otten RA, Qari SH, Jackson E, Cong M, Masciotra S, Luo W, Kim C, Adams DR, Monsour M, et al. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. PLoS Med 2008, 5:e28. 10.1371/journal.pmed.0050028, 2225435, 18254653.
9. Curtis KA, Kennedy MS, Luckay A, Cong ME, Youngpairoj AS, Zheng Q, Smith J, Hanson D, Heneine W, Owen SM, García-Lerma JG. Delayed maturation of antibody avidity but not seroconversion in Rhesus macaques infected with SHIV during oral pre-exposure prophylaxis. J Acquir Immune Defic Syndr 2011, 57:355-362. 10.1097/QAI.0b013e3182234a51, 21637113.
10. Kersh EN, Luo W, Zheng Q, Adams DR, Youngpairoj A, Cong M, McNicholl J, Hendry M, Heneine W, Garcia-Lerma JG. Oral PrEP during mucosal SHIV infection reduces viremia, preserves CD4 counts, and raises potent T cell responses. 18th International AIDS conference 2010, Vienna, Austria Oral presentation at symposium " Understanding HIV Transmission Mechanisms: Microbicides and PrEP" 2010,
11. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, Derdeyn CA, Farmer P, Hunter E, Allen S, Manigart O, Mulenga J, Anderson JA, Swanstrom R, Haynes BF, Athreya GS, Korber BT, Sharp PM, Shaw GM, Hahn BH. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol 2008, 82:3952-3970. 10.1128/JVI.02660-07, 2293010, 18256145.
12. Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, Rock D, Falloon J, Davey RT, Dewar RL, Metcalf JA, Hammer S, Mellors JW, Coffin JM. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol 2005, 43:406-413. 10.1128/JCM.43.1.406-413.2005, 540111, 15635002.
13. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 2008, 105:7552-7557. 10.1073/pnas.0802203105, 2387184, 18490657.
14. Liu J, Keele BF, Li H, Keating S, Norris PJ, Carville A, Mansfield KG, Tomaras GD, Haynes BF, Kolodkin-Gal D, Letvin NL, Hahn BH, Shaw GM, Barouch DH. Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. J Virol 2010, 84:10406-10412. 10.1128/JVI.01155-10, 2937794, 20686016.
15. Smith JM, Dauner A, Li B, Srinivasan P, Mitchell J, Hendry M, Ellenberger D, Butera S, Otten RA. Generation of a dual RT Env SHIV that is infectious in rhesus macaques. J Med Primatol 2010, 39:213-223. 10.1111/j.1600-0684.2010.00434.x, 20618587.
16. Stone M, Keele BF, Ma ZM, Bailes E, Dutra J, Hahn BH, Shaw GM, Miller CJ. A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251. J Virol 2010, 84:7083-7095. 10.1128/JVI.00481-10, 2898254, 20463069.
17. Loffredo JT, Maxwell J, Qi Y, Glidden CE, Borchardt GJ, Soma T, Bean AT, Beal DR, Wilson NA, Rehrauer WM, Lifson JD, Carrington M, Watkins DI. Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol 2007, 81:8827-8832. 10.1128/JVI.00895-07, 1951344, 17537848.
18. van Rompay KK, Dailey PJ, Tarara RP, Canfield DR, Aguirre NL, Cherrington JM, Lamy PD, Bischofberger N, Pedersen NC, Marthas ML. Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaques. J Virol 1999, 73:2947-2955. 104054, 10074144.
19. Watson A, McClure J, Ranchalis J, Scheibel M, Schmidt A, Kennedy B, Morton WR, Haigwood NL, Hu SL. Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques. AIDS Res Hum Retroviruses 1997, 13:1375-1381. 10.1089/aid.1997.13.1375, 9359657.
20. Boutwell CL, Rolland MM, Herbeck JT, Mullins JI, Allen TM. Viral evolution and escape during acute HIV-1 infection. J Infect Dis 2010, 202:S309-S314. 10.1086/655653, 2945609, 20846038.
21. Streeck H, Jolin JS, Qi Y, Yassine-Diab B, Johnson RC, Kwon DS, Addo MM, Brumme C, Routy JP, Little S, Jessen HK, Kelleher AD, Hecht FM, Sekaly RP, Rosenberg ES, Walker BD, Carrington M, Altfeld M. Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol 2009, 83:7641-7648. 10.1128/JVI.00182-09, 2708622, 19458000.
22. Cheng-Mayer C, Huang Y, Gettie A, Tsai L, Ren W, Shakirzyanova M, Sina ST, Trunova N, Blanchard J, Jenkins LM, Lo Y, Schito ML, Appella E. Delay of SHIV infection and control of viral replication in vaccinated macaques challenged in the presence of a topical microbicide. AIDS 2011, 25:1833-18841. 10.1097/QAD.0b013e32834a1d94, 21750420.
23. Li H, Bar KJ, Wang S, Decker JM, Chen Y, Sun C, Salazar-Gonzalez JF, Salazar MG, Learn GH, Morgan CJ, Schumacher JE, Hraber P, Giorgi EE, Bhattacharya T, Korber BT, Perelson AS, Eron JJ, Cohen MS, Hicks CB, Haynes BF, Markowitz M, Keele BF, Hahn BH, Shaw GM. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog 2010, 6:e1000890. 10.1371/journal.ppat.1000890, 2869329, 20485520.
24. Mehandru S, Poles MA, Tenner-Racz K, Manuelli V, Jean-Pierre P, Lopez P, Shet A, Low A, Mohri H, Boden D, Racz P, Markowitz M. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol 2007, 81:599-612. 10.1128/JVI.01739-06, 1797467, 17065209.
25. Harouse JM, Gettie A, Eshetu T, Tan RC, Bohm R, Blanchard J, Baskin G, Cheng-Mayer C. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J Virol 2001, 75:1990-1995. 10.1128/JVI.75.4.1990-1995.2001, 115146, 11160699.
26. Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999, 284:816-819. 10.1126/science.284.5415.816, 10221916.
27. Tamura K, Nei M, Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci U S A 2004, 101:11030-11035. 10.1073/pnas.0404206101, 491989, 15258291.
28. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599. 10.1093/molbev/msm092, 17488738.